Clinical Trial Update: Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy [NA]

View source ↗

Summary

This terminated clinical trial evaluated dolasetron mesylate and dexamethasone, with or without aprepitant, to prevent nausea and vomiting in patients undergoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Anzemet (dolasetron)
• Decadron (Dexamethasone)
• EMEND (aprepitant)

Snippet

Sponsor: University of Southern California | Conditions: Malignant Digestive System Neoplasm, Nausea and Vomiting | NA | Status: TERMINATED